(Q53538138)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

Erratum: NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2

23 February 2020

corrigendum / erratum

0 references

author

Philippe Bahadoran

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Corine Bertolotto

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Thierry Passeron

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Yann Cheli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Robert Ballotti

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

G M De Donatis

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

E Le Pape

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

A Pierron

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

V Hofman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

M Allegra

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

K Zahaf

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

S Rocchi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

P Hofman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

English

0 references

publication date

14 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

2735-2745

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/onc.2015.331

23 February 2020

exact match

0 references

cites work

Role of histone H3 lysine 27 methylation in Polycomb-group silencing

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

The role of EZH2 in tumour progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Unique polycomb gene expression pattern in Hodgkin's lymphoma and Hodgkin's lymphoma-derived cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

The polycomb group protein enhancer of zeste homolog 2 (EZH 2) is an oncogene that influences myeloma cell growth and the mutant ras phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

The polycomb group protein EZH2 is involved in progression of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Increased expression of EZH2, a polycomb group protein, in bladder carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Expression of polycomb group protein EZH2 in nevi and melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

EZH2-dependent chromatin looping controls INK4a and INK4b, but not ARF, during human progenitor cell differentiation and cellular senescence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21/CDKN1A expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Senescence surveillance of pre-malignant hepatocytes limits liver cancer development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Therapy-induced senescence in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

A novel NF-kappa B-inducing kinase-MAPK signaling pathway up-regulates NF-kappa B activity in melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

NF-κB inducing kinase: a key regulator in the immune system and in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

NF-κB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the β-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

PGJ2 antagonizes NF-kappaB-induced HIV-1 LTR activation in colonic epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Functions of NF-kappaB1 and NF-kappaB2 in immune cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Circuitry of nuclear factor kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Epigenetic regulation in human melanoma: past and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Senescence and aging: the critical roles of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

The essence of senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

The noncanonical NF-κB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Inhibiting NF-κB-inducing kinase (NIK): discovery, structure-based design, synthesis, structure-activity relationship, and co-crystal structures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Constitutive expression of lymphoma-associated NFKB-2/Lyt-10 proteins is tumorigenic in murine fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Constitutive non-canonical NFkappaB signaling in pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Activation of nuclear factor-kappa B signalling promotes cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Non-canonical NF-κB signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Non-canonical NF-κB signaling activation and regulation: principles and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

PI3K mediates protection against TRAIL-induced apoptosis in primary human melanocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

The melanocyte differentiation program predisposes to metastasis after neoplastic transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

p62 participates in the inhibition of NF-κB signaling and apoptosis induced by sulfasalazine in human glioma U251 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2015.331

31 March 2020

Identifiers

DOI

10.1038/ONC.2015.331

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26364600%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference